Value20202021202220232024TTMSelling/general/admin expenses2.56 B2.72 B2.88 B3.06 B3.1 B—Research & development307 M356 M345 M339 M289 M—Operating income295 M593 M450 M425 M657 M—Non-Operating Income, Total——————Interest expense, net of interest capitalized——————Non-Operating Income, excl. Interest Expenses——————Unusual income/expense——————Pretax income246 M586 M235 M290 M498 M—Equity in earnings——————Taxes202 M62 M12 M27 M86 M—Non-controlling/minority interest——————After tax other income/expense——————Net income before discontinued operations448 M524 M223 M263 M412 M—Discontinued operations——————Net income448 M524 M223 M263 M412 M—Dilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders——————Basic earnings per share (Basic EPS)——————Diluted earnings per share (Diluted EPS)——————Average basic shares outstanding——————Diluted shares outstanding——————EBITDA——————EBIT——————Cost of revenue1.4 B1.54 B1.54 B1.73 B1.76 B—Other cost of goods sold——————Depreciation & amortization (cash flow)234 M237 M229 M221 M230 M—
Smith & Nephew SNATS Inc
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.